Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REMission INDuction in Very Early Rheumatoid Arthritis

NCT02935387 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REMission INDuction in Very Early Rheumatoid Arthritis
Lead sponsor
UMC Utrecht
Phase
Phase 4
Overall status
Terminated
Start date
April 21, 2017
Completion date
January 9, 2019
Enrollment
53 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.